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Abstract Sulphated galactocerebroside (sulphatide) has been
established as a ligand for L-selectin and shown to trigger in-
tracellular signals in human neutrophils. We have found that
sulphatide activated transcription factor NF-UB in human neu-
trophils in a concentration-dependent manner whereas non-sul-
phated galactocerebroside did not demonstrate such an e¡ect.
The activation was inhibitable by pretreatment with primary
monoclonal anti-L-selectin antibody (clone LAM1-116). Binding
of the primary antibody to L-selectin was insu⁄cient to induce
NF-UB activation but cross-linking of L-selectin with a second-
ary antibody was e¡ective. K-Chymotrypsin, the agent known to
shed L-selectin, activated NF-UB by itself. The response to sul-
phatides was inhibited by jasplakinolide, an actin-polymerising
agent known to downregulate surface expression of L-selectin,
FcQRIIIb, CD43 and CD44. Recently we have reported that
sulphatide stimulated the attachment of human neutrophils to
collagen via Mac1 (CD11b/CD18) integrin [Sud’ina et al., Bio-
chem. J. 359 (2001) 621^629]. We now show signalling from
sulphatide to NF-UB activation and discuss its involvement in
neutrophil adhesion.
< 2003 Federation of European Biochemical Societies. Pub-
lished by Elsevier Science B.V. All rights reserved.
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1. Introduction
The transcription factor NF-UB plays a pivotal role in gene
expression of in£ammatory mediators such as cytokines and
adhesion molecules. NF-UB activation in human neutrophils
(polymorphonuclear leukocytes, PMN) has been shown to be
induced by the in£ammatory stimuli lipopolysaccharide (LPS)
and tumour necrosis factor-K (TNF) [1]. A temporal activa-
tion of NF-UB was observed in phagocytosing neutrophils [2].
It is known that cell attachment onto a surface can induce
activation of NF-UB, as had been shown on ¢broblast and
smooth muscle cells adhering to ¢bronectin [3]. It is not yet
known whether ligation of an adhesion molecule such as L-se-
lectin can activate NF-UB.
Sulphatide has been established as a ligand for L-selectin:
sulphatides speci¢cally bind to L-selectin receptors on neutro-
phils, while galactocerebrosides do not [4]. Sulphatide is a
typical component of myelin membranes and is also expressed
on plasma membranes. It is secreted by both myeloid and
tumour cells [5]. In neutrophils, sulphatides elicit several func-
tional responses, e.g. they stimulate oxidative metabolism and
induce massive superoxide production [6]. The role of sulpha-
tides as L-selectin signalling molecules was demonstrated also
by increasing cytosolic free calcium and enhancing expression
of TNF and interleukin-8 genes in human neutrophils [7]. We
have previously reported that sulphatides stimulated adhesion
of human neutrophils to surfaces coated with collagen and
¢bronectin [8]. Since this may proceed through an activation
for NF-UB we have now studied its activation in neutrophils
and found it triggered by sulphatides.
Sulphatide has been reported to activate leukocytes through
L-selectin-dependent and -independent pathways [9,10]. Be-
cause of evidence that peripheral blood granulocytes can
bind sulphatide after L-selectin shedding [10], we examined
whether L-selectin might transmit signal to NF-UB activation.
In the current study we show that L-selectins, when cross-
linked, are able to activate NF-UB in neutrophils.
Recent evidence has demonstrated that L-selectin ligation
and cross-linking upregulate Mac-1 surface expression [11,12].
In a recent publication [8] we have shown that sulphatide
induced Mac-1-mediated attachment of human neutrophils
to a collagen-coated surface. To determine if L-selectin was
necessary for sulphatide-induced attachment, we determined
PMN attachment to a collagen-coated surface after pretreat-
ment of PMN with K-chymotrypsin, phorbol myristate acetate
(PMA) and jasplakinolide, all known to induce L-selectin
shedding [7,10,13^15]. We found that the adhesive response
to sulphatide was abrogated in jasplakinolide-treated cells,
partly abolished in PMA-treated cells and slightly diminished
in K-chymotrypsin-treated cells. We conclude that L-selectin-
independent signalling contributes to sulphatide-induced at-
tachment of PMN to collagen.
2. Materials and methods
2.1. Reagents
Sulphatides and galactocerebrosides were obtained from Sigma
(Deisenhofen, Germany); recombinant human TNF was from Collab-
orative Biomedical Research (Bedford, MA, USA). All oligonucleo-
tides were kindly provided by Dr E.A. Romanova (Moscow State
University, Russia). T4 polynucleotide kinase was purchased from
SybEnzyme (Novosibirsk, Russia); poly(dI-dC) was from ICN (Cleve-
land, OH, USA); [Q-32P]ATP was from Isotope (Obninsk, Russia).
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Diisopropyl £uorophosphate (DFP) and 4-(2-aminoethyl)-benzenesul-
phonyl £uoride (AEBSF) were from Sigma (Deisenhofen, Germany);
leupeptin and pepstatin A were from Fluka (Buchs, Switzerland);
phenylmethylsulphonyl £uoride (PMSF) was from Nacalai Tesque
(Kyoto, Japan). Acid-soluble collagen type I was from Boehringer
Mannheim (Mannheim, Germany). Monoclonal anti-human L-selec-
tin antibody (mAb, clone LAM1-116) and monoclonal mouse IgG1
(clone MOPC31C) were from Alexis (Laufel¢ngen, Switzerland). Sec-
ondary, cross-linking goat anti-mouse IgG antibody (F(abP)2 frag-
ment) was from Sigma (Steinheim, Germany). All other reagents
were molecular biology grade.
2.2. Neutrophil isolation and stimulation
PMN were isolated from freshly drawn citrate-anticoagulated do-
nor blood. Leukocyte-rich plasma was prepared by 0.75% dextran
T-500 sedimentation of erythrocytes at room temperature. Granulo-
cytes were prepared from leukocyte-rich plasma by density gradient
centrifugation on a bilayer gradient of Ficoll-Paque (1.077 and 1.123
g/ml densities). Granulocytes were washed twice in phosphate-bu¡-
ered saline (PBS) bu¡er (0.144 g/l KH2PO4, 9 g/l NaCl, 0.795 g/l
Na2HPO4W7H2O, pH 7.4), resuspended at 107/ml in Dulbecco’s PBS
(PBS bu¡er containing 1 g/l glucose and 0.098 g/l MgSO4) without
calcium chloride, and stored at room temperature.
Puri¢ed cells were resuspended in Hanks’ bu¡er (phosphate bu¡er
pH 7.4, containing 140 mM NaCl, 1 mM CaCl2, 0.5 mM MgCl2, 5.6
mM glucose), at a ¢nal concentration of 5U106 cells/ml, and incuba-
ted at 37‡C in silicone-coated £asks with gentle agitation. Then sul-
phatides, galactocerebrosides or TNF were added to cells and incu-
bated for 20 min. In experiments with antibodies, aliquots of cells
were incubated with 7.5 Wg/ml anti-L-selectin or control mAb for
20 min at 37‡C. In cross-linking experiments, aliquots of cells were
¢rst incubated with 7.5 Wg/ml anti-L-selectin, then centrifuged, resus-
pended in Hanks’ bu¡er and incubated with 15 Wg/ml goat anti-mouse
F(abP)2. The incubations were terminated by adding ice-cold Dulbec-
co’s PBS supplemented with DFP (1 mM, ¢nal concentration), prior
to centrifugation at 1500Ug for 5 min at 4‡C.
2.3. Nuclear extract preparation and electrophoretic mobility shift
assay
Nuclear extracts were prepared by a modi¢ed Dignam procedure
[16], as follows. The pelleted cells were washed and resuspended in ice-
cold hypotonic bu¡er (bu¡er A: 10 mM HEPES, pH 7.5, 10 mM
KCl, 3 mM NaCl, 1 mM EDTA, 1 mM EGTA, 10 mM dithiothreitol
(DTT)) containing the following protease inhibitors: 1 mM PMSF,
2 mM DFP, 1 mM AEBSF, and 10 Wg/ml (¢nal concentration) each
of aprotinin, leupeptin, pepstatin A, and bestatin. After 20 min in-
cubation on ice, 0.1 volume of 2% NP-40 was added, the cells were
vortexed and immediately centrifuged at 14 000Ug for 1 min at 4‡C.
The pelleted nuclei were resuspended in ice-cold nuclear bu¡er (20
mM HEPES, pH 7.5, 25% glycerol, 400 mM NaCl, 1 mM EGTA,
1 mM EDTA, 10 mM DTT, 1% NP-40) containing the protease in-
hibitors described above. After 20 min incubation on ice the suspen-
sion was twice frozen and thawed in liquid nitrogen and then centri-
fuged (16 000Ug, 15 min, 4‡C). The supernatant (nuclear extract) was
aliquoted and stored in liquid nitrogen. Total protein concentration
was determined according to the method of Bradford.
The NF-UB DNA binding activity was determined by an electro-
phoretic mobility shift assay (EMSA). The oligonucleotide used as a
probe for EMSA was a 20-bp double-stranded construct 5P-GCC-
TCGGGATTTCCCATCTG-3P, 5P-CAGATGGGATTTCCCGGGA-
AATCCCGAGGC-3P (S), UB site is underlined. Mutant oligonucleo-
tide used in control experiments was 5P-GCCTCTCTATTTCCCAT-
CTG-3P, 5P-CAGATGGGAAATAGAGAGGC-3P (N). Nuclear ex-
tracts containing 8^12 Wg of protein in 10 Wl were incubated for 40
min on ice with 1 pmol of radiolabelled duplex (V200 000 cpm Cer-
enkov count) in 20 Wl binding bu¡er (20 mM HEPES, pH 7.5, 1 mM
EDTA, 10 mM DTT, 0.1% NP-40, 12% glycerol) supplemented with
20 Wg bovine serum albumin, 2 mM DFP, and 2 Wg poly(dI-dC). For
competition or supershift experiments the binding was performed in
the presence of 50U excess of unlabelled DNA duplex or 2 Wg of
speci¢c polyclonal anti-p65 (Rel A) antibody (Santa Cruz Biotechnol-
ogy, Santa Cruz, CA, USA), respectively. The mixture was incubated
for 20 min on ice prior to addition of 32P-labelled speci¢c DNA
duplex. The resulting complexes were resolved by electrophoresis on
6% non-denaturing polyacrylamide gel. The bands on the gel were
visualised on a phosphorimager (Molecular Dynamics PhosphoImag-
er SI, USA).
2.4. PMN adhesion assay
Myeloperoxidase was used as a marker enzyme to measure PMN
attachment to collagen adsorbed to plastic surfaces in static condi-
tions. Plastic 24-well tissue culture plates were coated with type I
collagen 75 Wg/ml for 24 h. Before use they were incubated for 1.5 h
in PBS with 0.2% human serum albumin, and then were thoroughly
washed with PBS. PMN (5U105/well) were added to collagen-coated
24-well culture plates in 500 Wl of Hanks’ balanced salt solution with
10 mM HEPES. After 30 min incubation in a CO2 incubator at 37‡C
to allow leukocyte adherence wells were washed two times with 500 Wl
PBS solution for removal of non-adherent PMN. The extent of
adherence was measured after the addition of detergent and a myelo-
peroxidase substrate as described [17,18]. 300 Wl of a solution of
5.5 mM ortho-phenylenediamine and 4 mM H2O2 in bu¡er (67 mM
Na2HPO4, 35 mM citric acid, 0.1% Triton X-100, pH 5) were added
to each well, and after 4 min, the reaction was stopped by the addition
of an equal volume of 1 M H2SO4. Standard dilutions of PMN with
or without tested compounds were used for calibration.
3. Results
To determine whether NF-UB was activated by sulphatides
in neutrophils, the cells were cultured in the presence of 50 Wg/
ml sulphatides for 20 min prior to nuclear extract preparation
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Fig. 1. Induction of NF-UB DNA binding activity in human neutro-
phils by sulphatides. Neutrophils were cultured for 20 min with 50
Wg/ml of sulphatides or galactocerebrosides (gal). As a positive con-
trol, neutrophils were also stimulated with 10 ng/ml rh TNF. Nu-
clear extracts were then prepared and analysed in EMSA using a
NF-UB DNA ligand S. Arrows indicate the positions of the three
DNA^protein complexes. The amount of protein in the binding re-
action was 5 Wg. The result is representative of three separate ex-
periments.
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and subsequent EMSA analysis. The e⁄ciency of NF-UB
binding to DNA (S) containing the UB recognition site was
tested. As a negative control, neutrophils were stimulated with
50 Wg/ml galactocerebrosides having the same glycolipid struc-
ture but lacking the sulphate group. As a positive control, the
cells were stimulated with TNF, a stimulus previously shown
to induce NF-UB in these cells [1].
As shown in Fig. 1, NF-UB binding activity (in C1 DNA^
protein complex) was enhanced in nuclear extracts from sul-
phatide- and TNF-treated neutrophils. The non-sulphated
analogue of sulphatide, galactocerebroside, had no e¡ect on
NF-UB activation. The speci¢city of DNA^protein interaction
was con¢rmed by experiments with addition of excess unla-
belled DNA duplex (S) containing a UB site as well as non-
speci¢c duplex (N). The speci¢c DNA ligand reduced the
amount of radioactive DNA^protein complex due to compet-
itive binding, while the non-speci¢c duplex did not (Fig. 2A).
NF-UB in neutrophils is well-characterised [1]. Therefore to
prove the protein component of the DNA^protein complex
we used only one type of antiserum, namely, antiserum
against the p65 subunit of NF-UB. As shown in Fig. 2B,
antiserum to p65 subunit completely supershifted the speci¢c
DNA^protein complex. This fact allowed us to conclude that
the complex contained the p65 subunit of NF-UB.
Some studies [19,20] dealing with NF-UB in neutrophils
underline the problem of NF-UB degradation in the course
of preparing the nuclear extract. Our method and a spectrum
of inhibitors employed allowed us to obtain the nuclear ex-
tract with the complete content of NF-UB protein. The speci¢c
DNA^protein complex from the nuclear extract of neutrophils
comigrated with the speci¢c DNA^protein complex from nu-
clear extracts of human umbilical vein endothelial cells (data
not shown). Data presented in Fig. 3 show that sulphatides
activated NF-UB in a concentration-dependent manner.
To prove more de¢nitely that L-selectin ligation can lead to
NF-UB activation, NF-UB binding activity was determined in
nuclear extracts from PMN incubated with primary anti-L-
selectin antibody. We observed that binding of the primary
antibody alone was insu⁄cient to induce activation of NF-UB
(Fig. 4). Accordingly, the e¡ect of cross-linking L-selectin on
NF-UB activation was examined. Cells were treated with pri-
mary anti-L-selectin mAb, washed, resuspended and incuba-
ted with goat anti-mouse Ig F(abP)2 fragment. After addition
Fig. 2. Competition (A) and supershift (B) analysis of the DNA^
protein complexes formed in response to sulphatides. A: Nuclear
extracts were incubated with a 32P-labelled NF-UB-speci¢c DNA li-
gand S in the presence of a 50-fold excess of unlabelled non-speci¢c
DNA ligand N (lane 1), or speci¢c DNA ligand S (lane 2). B: Nu-
clear extracts were incubated in the absence (lane 1) or in the pres-
ence (lane 2) of antibody raised against p65/RelA prior to the addi-
tion of labelled NF-UB-speci¢c DNA ligand S and subsequent
EMSA analysis.
Fig. 3. Sulphatides activate NF-UB in a concentration-dependent
manner. Neutrophils were incubated with di¡erent concentrations of
sulphatides and then nuclear extracts were prepared and assayed for
NF-UB binding activity to 32P-labelled speci¢c DNA ligand S by
EMSA. The arrow indicates the position of the inducible complex.
The amount of nuclear extract used was 4 Wg of protein. The results
are representative of three experiments.
Fig. 4. A: Cross-linking of L-selectin leads to NF-UB activation.
Neutrophils were incubated with 7.5 Wg/ml anti-L-selectin (2,3) or
control (1) mAb for 20 min at 37‡C, washed, centrifuged, resus-
pended and incubated without (1,3) or with 15 Wg/ml goat anti-
mouse F(abP)2 fragment (2). Nuclear extracts were then prepared
and analysed for NF-UB binding activity (see legend to Fig. 3). The
amount of protein in the binding reaction was 5 Wg. The result is
representative of three experiments. B: Activation of NF-UB by sul-
phatides is inhibited by anti-L-selectin mAb. Neutrophils were incu-
bated with 10 Wg/ml anti-L-selectin (3,4) or control (5,6) mAb for
15 min at 37‡C, then vehicle (1,4,5) or 50 Wg/ml sulphatides (2,3,6)
were added for 20 min at 37‡C. Nuclear extracts were then prepared
and analysed for NF-UB binding activity (see legend to Fig. 3). The
amount of protein in the binding reaction was 9 Wg. The result is
representative of two experiments.
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of the cross-linking antibody, NF-UB activation was clearly
indicated (Fig. 4A).
To distinguish L-selectin-dependent and -independent com-
ponents in sulphatide signalling, neutrophils were preincu-
bated with anti-L-selectin mAb (LAM1-116) prior to the ad-
dition of sulphatides. L-selectin ligation with primary
antibody inhibited the sulphatide-mediated response (Fig.
4B). Neutrophils were incubated with K-chymotrypsin or jas-
plakinolide, which produced shedding of L-selectin [7,13^15],
before the addition of sulphatides. Both treatments abrogated
the response to sulphatide, but K-chymotrypsin itself activated
NF-UB in PMN (Fig. 5). PMA could also shed surface
L-selectin [10], but activated NF-UB [1].
Sulphatides and L-selectin cross-linking both activated NF-
UB transcription factor. It is known that L-selectin cross-link-
ing [12,21] and sulphatides [8] induce activation of L2 integ-
rins. Do they signal in a similar way to PMN attachment onto
a collagen-coated surface? Unlike sulphatides, the cross-link-
ing did not induce PMN attachment to the surface (Table 1).
To exclude binding of sulphatide to L-selectin in sulphatide^
PMN interactions, we treated PMN with K-chymotrypsin,
which is known to shed speci¢cally L-selectin from the cell
surface [7,13,14]. K-Chymotrypsin-treated cells preserved the
ability to interact with sulphatides resulting in increased ad-
hesion (about 60% of that of control-treated cells). Thus,
sulphatides could activate PMN by L-selectin-dependent and
-independent pathways. L-selectin-independent binding of sul-
phatides can be induced by the treatment of cells with PMA
[10]. 10 min cell treatment with PMA corresponds to minimal
L-selectin expression and minimal binding of sulphatide [10].
In these conditions PMA lowered the response to sulphatide
from 73% (without PMA) to 13% (Table 1). 30 min cell treat-
ment with PMA results in an increase of L-selectin-indepen-
dent sulphatide binding [10] and an increase of PMN attach-
ment (Table 1) that proves L-selectin-independent signaling to
adhesion. Jasplakinolide, which is known to shed many sur-
face receptors [15], totally abolished the response to sulpha-
tide (Table 1).
4. Discussion
Activation of the NF-UB pathway in neutrophils occurs by
the action of in£ammatory stimuli like LPS, TNF and reactive
Fig. 5. K-Chymotrypsin and jasplakinolide pretreatments inhibit the
response to sulphatides. Lines 1,2: Neutrophils were incubated with-
out (1) or with (2) 50 Wg/ml sulphatides for 20 min at 37‡C. Lines
3,4: Neutrophils were incubated with 10 U/ml chymotrypsin for 10
min at 37‡C. After washing the cells were untreated (3) or stimu-
lated (4) with 50 Wg/ml sulphatides for 20 min at 37‡C. Lines 5,6:
Neutrophils were incubated with 500 nM jasplakinolide+50 Wg/ml
sulphatides (5) or only with 500 nM jasplakinolide (6) for 20 min at
37‡C. Nuclear extracts were then prepared and analysed for NF-UB
binding activity (see legend to Fig. 3). The amount of protein in the
binding reaction was 9 Wg. The result is representative of two ex-
periments.
Table 1
E¡ect of K-chymotrypsin, jasplakinolide and PMA on sulphatide-stimulated attachment of human neutrophils to collagen
PMN^collagen interactions PMN attachment to the surface (% of added cells)
Control 2.0T 0.7
Sulphatides, 50 Wg/ml 73T 9
Galactocerebrosides, 50 Wg/ml 2.2T 0.8
Anti-L-selectin 2.0T 1.1
L-selectin cross-linking 2.0T 0.9
Jasplakinolide, 500 nM 1.5T 0.5
Jasplakinolide (500 nM)+sulphatide (50 Wg/ml) 2.0T 0.8
K-Chymotrypsin-treated cells Control 3.4T 0.8
Sulphatide 46T 5.8
PMA-treated cells Control 33T 4.0
(10 min) Sulphatide 13T 1.9
PMA-treated cells Control 7.3T 1.2
(30 min) Sulphatide 24T 3.1
Cells were incubated on a collagen-coated plastic surface without (control) or with 50 Wg/ml sulphatides or 50 Wg/ml galactocerebrosides for 30
min at 37‡C. In experiments with mAbs the cells were pretreated with 7.5 Wg/ml anti-L-selectin, washed, resuspended and incubated on a colla-
gen-coated surface without or with 15 Wg/ml goat anti-mouse F(abP)2 fragment. In experiments with K-chymotrypsin, neutrophils were incuba-
ted with 10 U/ml chymotrypsin for 10 min at 37‡C. After washing, the cells were resuspended and incubated on a collagen-coated surface with-
out or with 50 Wg/ml sulphatides for 30 min at 37‡C. In experiments with jasplakinolide neutrophils were incubated on a collagen-coated
surface with 500 nM jasplakinolide or with 500 nM jasplakinolide and 50Wg/ml sulphatides for 30 min at 37‡C. In experiments with PMA neu-
trophils were incubated with 100 nM PMA for 10 or 30 min at 37‡C. After washing, the cells were resuspended and incubated on a collagen-
coated surface without or with 50 Wg/ml sulphatides for 30 min at 37‡C. Percentage of adherent cells was determined after washing of non-ad-
herent cells as described in Section 2. PMN attachment is expressed as percentage of PMN adhering in relation to the total number of PMN
added. Values shown are the meansTS.D. of three experiments, each run in duplicate.
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oxygen species. In vivo studies with sulphatides demonstrate
that they have signi¢cant protective e¡ects in neutrophil- and
selectin-dependent models of lung injury [22]. In the current
study we have for the ¢rst time demonstrated that sulphatide
activated the transcription factor NF-UB and did it speci¢cally
since a non-sulphated analogue did not activate NF-UB.
Furthermore, we have shown that sulphatide signalling
leading to NF-UB activation is L-selectin-dependent. This ef-
fect was not seen after treatment with galactocerebrosides
which have the same glycolipid structure but lack the sulphate
group and therefore do not bind L-selectin [23]. L-selectin
ligation with primary anti-L-selectin mAbs inhibited the sul-
phatide-mediated NF-UB activation. K-Chymotrypsin selec-
tively cleaves L-selectin [7,13,14], but no other neutrophil sur-
face antigens from the cell surface, and we studied the e¡ect of
sulphatide on K-chymotrypsin-pretreated cells. We could not
prove the lack of e¡ect of sulphatide as K-chymotrypsin itself
activated NF-UB. Jasplakinolide, known to downregulate cell
surface expression of FcQRIIIb, CD43, CD44 and L-selectin
[15], abolished NF-UB activation as well as sulphatide-induced
attachment.
Using a primary antibody to L-selectin and cross-linking
with a secondary antibody, we provide evidence that binding
of the primary antibody alone to L-selectin is insu⁄cient to
activate NF-UB but cross-linking with a secondary antibody is
required.
It is known that sulphatide induces TNF gene expression in
human neutrophils [7] and TNF is a potential activator of
NF-UB in human neutrophils. A number of UB binding sites
is present in the regulatory region of mammalian TNF genes
[24] and NF-UB binding is crucial for transcription of these
genes [25]. Activation of the TNF promoter is mediated by
NF-UB activation in cell response to many stimuli [26,27]. We
propose that NF-UB activation promotes TNF gene expres-
sion in neutrophils treated with sulphatides. It is known that
TNF is produced in a membrane-bound form and for TNF
secretion the activity of sheddase is required [28]. In the fast
response to sulphatides it is di⁄cult to propose intermediate
stages with TNF synthesis and shedding.
Our data suggest that NF-UB activation could be causally
related to sulphatide-induced adhesion of neutrophils to solid
surfaces coated by collagen. But the signalling pathways from
sulphatides to NF-UB activation and to stimulation of the
attachment seem to be distinct. K-Chymotrypsin, known to
shed L-selectin, was unable to prevent sulphatide-stimulated
attachment to collagen in agreement with the notion of L-se-
lectin-independent binding of sulphatides to peripheral blood
granulocytes [10]. We conclude that L-selectin-independent
signalling contributes to sulphatide-induced adhesion. That
jasplakinolide totally abolished the response to sulphatide
one could propose from its ability to shed many surface re-
ceptors [15] and to sti¡en cells blocking their ability to spread
on the surface.
Based on the similar e¡ects of sulphatide and L-selectin
cross-linking on NF-UB activation, we expected also to ¢nd
an increased attachment of PMN to the collagen-coated sur-
face after L-selectin cross-linking as we observed after sulpha-
tide. According to our data, this was not the case and we
argue for a di¡erent signalling between adhesion by sulphatide
and by L-selectin cross-linking.
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